VAC-IE regimen
Term · Oncology and biomedicine · MLC-T-ONC-009130
An abbreviation for a chemotherapy combination used to treat Ewing sarcoma and other sarcomas, such as mesenchymal chondrosarcoma. It includes the drugs vincristine sulfate, doxorubicin hydrochloride (Adriamycin), and cyclophosphamide, followed by ifosfamide and etoposide phosphate. Also called VAC-IE, VAdriaC-IE, and VAdriaC-IE regimen.
| Identifier | MLC-T-ONC-009130 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | VAC-IE; VAdriaC-IE; VAdriaC-IE regimen |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-009130",
"term": "VAC-IE regimen",
"field": "Oncology and biomedicine",
"definition": "An abbreviation for a chemotherapy combination used to treat Ewing sarcoma and other sarcomas, such as mesenchymal chondrosarcoma. It includes the drugs vincristine sulfate, doxorubicin hydrochloride (Adriamycin), and cyclophosphamide, followed by ifosfamide and etoposide phosphate. Also called VAC-IE, VAdriaC-IE, and VAdriaC-IE regimen.",
"synonyms": [
"VAC-IE",
"VAdriaC-IE",
"VAdriaC-IE regimen"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/vac-ie-regimen/"
}
Record 17,062 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.